These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11550165)

  • 1. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.
    Baorto EP; Aquino VM; Mullen CA; Buchanan GR; DeBaun MR
    Cancer; 2001 Aug; 92(4):909-13. PubMed ID: 11550165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia.
    Madsen K; Rosenman M; Hui S; Breitfeld PP
    J Pediatr Hematol Oncol; 2002 May; 24(4):256-62. PubMed ID: 11972092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
    Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
    Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the risk of bacteremia in childen with fever and neutropenia.
    Rackoff WR; Gonin R; Robinson C; Kreissman SG; Breitfeld PB
    J Clin Oncol; 1996 Mar; 14(3):919-24. PubMed ID: 8622040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patients.
    Urbonas V; Eidukaitė A; Tamulienė I
    Cytokine; 2012 Mar; 57(3):313-5. PubMed ID: 22189417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute Monocyte Count as Early and Safe Marker for Antibiotic Cessation in Febrile Neutropenia Without Etiology in Pediatric Oncology Patients.
    Alali M; Prather C; Danziger-Isakov LA; Kussin ML; Khalifeh M; Al Othman N; Bartlett AH
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):e702-e709. PubMed ID: 37494607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of febrile, nonneutropenic pediatric oncology patients with central venous catheters who are not given empiric antibiotics.
    Bartholomew F; Aftandilian C; Andrews J; Gutierrez K; Luna-Fineman S; Jeng M
    J Pediatr; 2015 Jan; 166(1):157-62. PubMed ID: 25444524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-risk febrile neutropenia in a medical oncology unit.
    Leong DC; Kinlay S; Ackland S; Bonaventura A; Stewart JF
    Aust N Z J Med; 1997 Aug; 27(4):403-7. PubMed ID: 9448881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia.
    Urbonas V; Eidukaitė A; Tamulienė I
    Cytokine; 2013 Apr; 62(1):34-7. PubMed ID: 23510625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Depth of Neutropenia and Clinical Outcomes in Febrile Pediatric Cancer and/or Patients Undergoing Hematopoietic Stem-cell Transplantation.
    Alali M; David MZ; Danziger-Isakov LA; Bartlett AH; Petty LA; Schwartz T; Pisano J
    Pediatr Infect Dis J; 2020 Jul; 39(7):628-633. PubMed ID: 32176187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6, interleukin-8, interleukin-10, and C-reactive protein in febrile neutropenia in children with malignant diseases.
    Spasova MI; Terzieva DD; Tzvetkova TZ; Stoyanova AA; Mumdzhiev IN; Yanev IB; Genev ED
    Folia Med (Plovdiv); 2005; 47(3-4):46-52. PubMed ID: 16761394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory parameter dynamics as markers of blood stream infections in pediatric oncology patients with fever and neutropenia.
    Hazan G; Ben-Shimol S; Fruchtman Y; Abu-Quider A; Kapelushnik J; Moser A; Falup-Pecurariu O; Greenberg D
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):e275-9. PubMed ID: 24276046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fever and neutropenia in children with solid tumors is similar in severity and outcome to that in children with leukemia.
    Koçak U; Rolston KV; Mullen CA
    Support Care Cancer; 2002 Jan; 10(1):58-64. PubMed ID: 11778605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary tract infections in pediatric oncology patients with fever and neutropenia.
    Sandoval C; Sinaki B; Weiss R; Munoz J; Ozkaynak MF; Tugal O; Jayabose S
    Pediatr Hematol Oncol; 2012 Feb; 29(1):68-72. PubMed ID: 22304012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Admission clinical and laboratory factors associated with death in children with cancer during a febrile neutropenic episode.
    Santolaya ME; Alvarez AM; Avilés CL; Becker A; Mosso C; O'Ryan M; Payá E; Salgado C; Silva P; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M
    Pediatr Infect Dis J; 2007 Sep; 26(9):794-8. PubMed ID: 17721373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between neutropenia and the incidence of bacteremia associated with indwelling central venous catheters in febrile pediatric cancer patients.
    Gorelick MH; Owen WC; Seibel NL; Reaman GH
    Pediatr Infect Dis J; 1991 Jul; 10(7):506-10. PubMed ID: 1876466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-8 predicts pediatric oncology patients with febrile neutropenia at low risk for bacteremia.
    Cost CR; Stegner MM; Leonard D; Leavey P
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):206-11. PubMed ID: 23425997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia.
    Lehrnbecher T; Venzon D; de Haas M; Chanock SJ; Kühl J
    Clin Infect Dis; 1999 Aug; 29(2):414-9. PubMed ID: 10476751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of discharge for children with cancer and febrile neutropenia off antibiotics using absolute neutrophil count threshold values as a surrogate marker for adequate bone marrow recovery.
    Campbell ME; Friedman DL; Dulek DE; Zhao Z; Huang Y; Esbenshade AJ
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital.
    Griffin TC; Buchanan GR
    J Pediatr; 1992 Jul; 121(1):28-33. PubMed ID: 1625089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.